Covalent coupling of tuberculostatic agents and graphene oxide: A promising approach for enhancing and extending their antimicrobial applications
Source abstract
Abstract
Abstract In this work, we present a simple, two-stage method for the preparation of new and efficient antimicrobial hybrid systems, based on isoniazid and pyrazine-2-carbohydrazide tuberculostatic agents covalently linked to graphene oxide. In the first step, the carboxyl groups of graphene oxide are activated by transforming them into the corresponding acid chloride groups, which, in the second step, will react with the amino groups of the two drugs. Pyrazine-2-carbohydrazide was obtained from pyrazinoic acid and hydrazine hydrate and was confirmed by nuclear magnetic resonance spectroscopy. The materials have been characterized by elemental analysis, infrared spectroscopy, Raman spectroscopy, scanning electron microscopy, and X-ray photoelectron spectroscopy. Their antimicrobial activity was tested on mycobacterial (Mycobacterium terrae), as well as on Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853), Gram-positive bacteria (Staphylococcus aureus ATCC 6538, Staphylococcus aureus ATCC 25923) and fungal (Candida albicans ATCC 10231), in planktonic and biofilm growth state. The biocompatibility of the tested compounds was assessed in vitro by live-dead fluorescence staining and flow cytometry. The results of this study have shown that the functionalization of graphene oxide with isoniazid and pyrazine-2-carbohydrazide both enhanced the anti-mycobacterial activity of the respective drugs and extended their antimicrobial spectrum towards other microbial strains, in planktonic and biofilm growth state, showing a promising potential for mitigating the impact of antimicrobial resistance and the deleterious effects of microbial biofilms. At the active tuberculostatic concentrations, the tested compounds exhibit very low cytotoxicity and do not interfere with the cellular cycle of Hep-2 cells. The flow cytometry and live/dead fluorescence staining proved that the tested compounds exhibit a microbicidal effect through induction of cellular lesions, consecutive to membrane depolarization.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Electric field effect in atomically thin carbon films10.1126/science.1102896 ↗
2. Graphene field-effect transistors with high on/off current ratio and large transport band gap at room temperature10.1021/nl9039636 ↗
3. Low-temperature solution processing of graphene-carton nanotube hybrid materials for high-performance transparent conductor10.1021/nl9001525 ↗
4. Graphene fluorescence resonance energy transfer aptasensor for thrombin detection10.1021/ac9025384 ↗
5. Prostate cancer targeted multifunctionalized grapheme oxide for magnetic resonance imaging and drug delivery10.1016/j.carbon.2016.05.054 ↗
6. Curcumin-reduced graphene oxide sheets and their on human breast cancer cells10.1016/j.msec.2015.05.077 ↗
7. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide10.1016/j.msec.2015.10.065 ↗
8. Graphene-based nanomaterials for drug delivery and tissue engineering10.1016/j.jconrel.2013.10.017 ↗
9. Covalently grafted tempo on graphene oxide: a composite material for selective oxidation of alcohols10.1016/j.carbon.2016.05.006 ↗
10. Synergistic bacteria-killing through photodynamic and physical actions of graphene oxide/Ag/collagen coating
11. Cytotoxicity of graphene oxide nanoparticles on plant growth promoting rhizobacteria10.1016/j.jiec.2015.08.027 ↗
12. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa10.2147/IJN.S37397 ↗
13. Fluorescein isothiocyanate conjugated graphene oxide for detection of dopamine10.1016/j.matchemphys.2012.12.069 ↗
14. Covalently functionalized graphene sheets with biocompatible natural amino acids10.1016/j.apsusc.2014.04.070 ↗
15. A graphene hybrid covalently functionalized with porphyrin: synthesis and optical limiting property10.1002/adma.200801617 ↗
16. High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide10.1021/jp806751k ↗
17. Covalent functionalization of polydisperse chemically-converted graphene sheets with amine-terminated ionic liquid
18. Nanomolar detection of dopamine in the presence of ascorbic acid at β-cyclodextrin/graphene nanocomposite platform10.1016/j.elecom.2010.01.042 ↗
19. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel10.1016/j.ejpb.2015.03.022 ↗
20. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery10.1002/smll.201100191 ↗
21. Synthesis and drug-delivery behavior of chitosan functionalized graphene oxide hybrid nanosheets10.1002/mame.201000307 ↗
22. Global and regional burden of isoniazid-resistant tuberculosis10.1542/peds.2015-0172 ↗
23. Tryptophan and thiosemicarbazide derivatives: design, synthesis, and β-D-glucosidase inhibitors10.1007/s00044-014-1314-4 ↗
24. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses10.1128/AAC.00630-11 ↗
25. Rosmarinus officinalis essential oil and eucalyptol act as efflux pumps inhibitors and increase ciprofloxacin efficiency against Pseudomonas aeruginosa and Acinetobacter aeruginosa and Acinetobacter baumannii MDR strains
26. Improved synthesis of graphene oxide
27. N,N-dimethylbiguanide complexes displaying low cytotoxicity as potential large spectrum antimicrobial agents10.1016/j.ejmech.2010.03.033 ↗
28. Deae-cellulose/Fe3O4/cephalosporins hybrid materials for targeted drug delivery
29. Detection identification and susceptibility testing of bacteria by flow cytometry
30. Review use of fluorescent probes to assess physiological functions of bacteria at single-cell level10.1016/S1286-4579(00)01307-1 ↗
31. Synthesis, oxidation potential and ati-mycobacterial activity of isoniazid and analogyes: insights into the molecular isoniazid activation mechanism10.1002/slct.201600040 ↗
32. New alternatives to graphite for producing graphene materials10.1016/j.carbon.2015.05.105 ↗
33. Spectra of graphite oxide and functionalized graphene sheets10.1021/nl071822y ↗
34. Raman spectroscopy as a versatile tool for studying the properties of grapheme10.1038/nnano.2013.46 ↗
35. A Raman spectroscopic investigation of graphite oxide derived grapheme
36. Characterization of graphite fiber surfaces with Raman spectroscopy10.1177/002199837000400405 ↗
37. A new raman metric for the characterisation of graphene oxide and its derivatives10.1038/srep19491 ↗
38. Quantitative structural and textural assessment of laminar pyrocarbons through Raman spectroscopy, electron diffraction and few other techniques10.1016/j.carbon.2005.12.029 ↗
39. Recent advances in laser utilization in the chemical modification of graphene oxide and its applications10.1002/adom.201500469 ↗
40. Reduced graphene oxide by chemical graphitization10.1038/ncomms1067 ↗
41. FTIR, FT Raman spectra and molecular structural confirmation of isoniazid
42. Different approaches for preparing a novel thiol-functionalized graphene oxide/Fe-Mn and its application for aqueous methylmercury removal10.1016/j.cej.2017.03.015 ↗
43. High-quality graphene via microwave reduction of solution-exfoliated graphene oxide10.1126/science.aah3398 ↗
44. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis10.1016/j.meegid.2016.09.004 ↗
45. New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens10.1016/j.ijmyco.2016.08.009 ↗
46. Synthesis and characterization of pyrazine-2-carbohydrazide derivatives as antimicrobial agents10.4103/0975-1483.55750 ↗
47. Synthesis of graphene oxide-quaternary ammonium nanocomposite with synergistic antibacterial activity to promote infected wound healing
48. Anti-bacterial activity of graphene oxide as a new weapon nanomaterial to combat multidrug-resistance bacteria10.1016/j.msec.2016.12.125 ↗
49. Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress10.1021/nn202451x ↗
50. Antibacterial applications of graphene-based nanomaterials: recent achievements and challenges10.1016/j.addr.2016.04.009 ↗
51. New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens10.1016/j.ijmyco.2016.08.009 ↗
52. The future development of bacteria fighting medical devices: the role of graphene oxide10.1080/17434440.2016.1245612 ↗
53. The graphene oxide contradictory effects against human pathogens10.1088/1361-6528/aa6150 ↗
54. Mycobacterium terrae: a potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test10.1016/S0195-6701(98)90273-0 ↗
55. Mycobactericidal testing of disinfectants: an update. Sattar SA110.1016/0195-6701(95)90041-1 ↗
56. Antimicrobial and antibiofilm efficacy of graphene oxide against chronic wound microorganisms
57. Gauthier · Med. Microbiol. · 2002 · 51 · 19210.1099/0022-1317-51-3-192 ↗
58. Rapid cytometric antibiotic susceptibility testing utilizing adaptive multidimensional statistical metrics10.1021/ac504241x ↗